Initial Physical Therapy vs. Surgery in Patients with Severe Hip Osteoarthritis
Although prescribing a trial of physical therapy before referral for total hip arthroplasty (THA) is common practice, we don’t have comparisons of
Related Articles
McCune–Albright Syndrome | NEJM
A 3-year-old boy presented with an 18-month history of bowing of the left leg that impaired his ability to walk. In addition, testicular enlargement and…
An Improved Alert System for Emerging Infectious Diseases
This Viewpoint investigates the lack of a comprehensive infectious diseases alert system in the US and proposes solutions for such a system, including linking changing…
Clinical Variant Reclassification in Hereditary Disease Genetic Testing
This cohort study analyzes the rates at which clinical genetic variants are reclassified and the types of evidence that enable reclassification among individuals who undergo…
A History of Concussion Linked to Maternal Mental Illness
Women with a history of concussion were 25% more likely to have a serious mental illness in the years after childbirth than those without a…
Simple Strategies to Reduce Cardiac Strain in Older Adults in Extreme Heat | NEJM
In this crossover trial in older adults with or without coronary artery disease, cardiac strain was reduced with fan use, skin wetting, or both in…
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S. pharmaceuticals segment on robust demand for specialty…
Uterine Fibroids | NEJM
Uterine fibroids, a frequent cause of heavy bleeding and anemia, are common. Hysterectomy is the most common treatment, but safer options, such as localized ablation…
Rideshare drivers in Massachusetts can unionize without being full-time employees
Massachusetts has passed a statewide ballot initiative that gives rideshare drivers the opportunity to unionize while remaining independent contractors.
Novo’s earnings report sends shares up, as obesity drug sales show continued growth
Novo Nordisk shares were up Wednesday following an earnings report that showed continued sales growth of its obesity drug.
